OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	445
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	305
Endocrine Manifestations and New Developments in Mitochondrial Disease	261
How Protein Methylation Regulates Steroid Receptor Function	233
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	227
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	194
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	193
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	172
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	169
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	165
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures	151
The Molecular Biology of Midgut Neuroendocrine Neoplasms	147
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	130
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	114
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	106
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	89
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	82
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	81
The Biology and Clinical Implications of PCSK7	74
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	73
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	71
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	71
Estrogen Receptor Signaling in the Immune System	69
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	67
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	67

Contemporary Biological Insights and Clinical Management of Craniopharyngioma	64
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	59
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	57
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	57
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	55
The Metabolic Role and Therapeutic Potential of the Microbiome	54
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	52
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	51
Adiponectin and Adiponectin Receptors in Atherosclerosis	49
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	48
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	48
The Cortisol Awakening Response: Regulation and Functional Significance	47
Imaging of Pheochromocytomas and Paragangliomas	46
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	46
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	45
Brown Adipose Tissue—A Translational Perspective	40
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	39
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	38
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	37
Endocrine Controls of Skin Aging	36
A Modern Approach to Dyslipidemia	36
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	36
Medullary Thyroid Cancer: Updates and Challenges	36
Protective Factors and the Pathogenesis of Complications in Diabetes	35
Epidemiology, genetic etiology and intervention of premature ovarian insufficiency	34
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	32
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification	31
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors	31
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	31
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	30
Teprotumumab for the Treatment of Thyroid Eye Disease	30
The Role of Iodine for Thyroid Function in Lactating Women and Infants	30
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma	29
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	28
Update on Adipose Tissue and Cancer	27
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	27
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	26
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	25
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	25
Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	23
Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants	23
A Clinical Update on Gestational Diabetes Mellitus	23
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	22
Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types	22
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	21
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	21
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	21
Endocrine Dysfunction in Primary Mitochondrial Diseases	20
Peptidergic G Protein–Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back	19
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	19

Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk